Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study (Q44962370)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 1, 1995

Language	Label	Description	Also known as
English	Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study	scientific article published on May 1, 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Smith JA Jr

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

D. L. Lamm

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

B. A. Blumenstein

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

E. David Crawford

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

J. D. Crissman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

B. A. Lowe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

J. A. Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

M. F. Sarosdy

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

P. F. Schellhammer

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

A. I. Sagalowsky

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

E. M. Messing

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

P. Loehrer

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

H. Barton Grossman

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21224104

21 November 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

May 1995

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21224104

21 November 2024

full work available at URL

https://api.elsevier.com/content/article/PII:107814399500041F?httpAccept=text/xml

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

https://api.elsevier.com/content/article/PII:107814399500041F?httpAccept=text/plain

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

119-126

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma

2

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study

3

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

4

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers

7

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial

8

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group

9

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation

12

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Designs for group sequential tests.

13

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

14

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients

18

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer

20

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Bone marrow suppression after intravesical mitomycin C treatment

22

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Intravesical therapy: does it affect the natural history of superficial bladder cancer?

23

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer

24

1 reference

10.1016/1078-1439(95)00041-F

https://api.crossref.org/works/10.1016/1078-1439(95)00041-F

21 November 2024

Identifiers

10.1016/1078-1439(95)00041-F

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

release_f3apgnr34va4ro44a2zx4dzk4q

1 reference

https://api.fatcat.wiki/v0/release/f3apgnr34va4ro44a2zx4dzk4q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44962370&oldid=2278102105"